Clinical Cancer Research Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palayoor, S. T.
Right arrow Articles by Coleman, C. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palayoor, S. T.
Right arrow Articles by Coleman, C. N.

Clinical Cancer Research, Vol 4, Issue 3 763-771, Copyright © 1998 by American Association for Cancer Research


ARTICLES

Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells

ST Palayoor, EA Bump, SK Calderwood, S Bartol and CN Coleman
Joint Center for Radiation Therapy, Harvard Medical School, Boston, Massachusetts 02215, USA. SPALAYOOR@JCRT.harvard.edu

Recent clinical observations indicate that ibuprofen may alleviate the radiation-induced dysuria that almost invariably occurs during radiation therapy for prostate cancer. Because the use of ibuprofen could consequently become common during radiation therapy for prostate cancer, we have been interested in the potential interactions between ibuprofen and ionizing radiation on prostate tumor cells. The effects of gamma-irradiation and/or ibuprofen on PC3 and DU-145 human prostate carcinoma cells were evaluated in vitro using three model systems. Clonogenic survival was determined by plating cells 24 h after treatment of nearly confluent monolayers. Analysis of cell growth, cell detachment, and apoptotic cell death was carried out over a period of up to 9 days after treatment of PC3 and DU-145 monolayers. The effect of ibuprofen and/or radiation was also probed by observing the inhibition of growth of established PC3 and DU-145 colonies that were treated on the 14th day of colony growth. Ibuprofen enhanced the radiation response of prostate cancer cells in all three in vitro models. Both the cytotoxic and radiosensitizing effects of ibuprofen seem to require concentrations that are higher than those reported to inhibit prostaglandin synthesis, suggesting that other molecular mechanisms may be responsible for ibuprofen cytotoxicity.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. T. Palayoor, M. J. Arayankalayil, A. Shoaibi, and C. N. Coleman
Radiation Sensitivity of Human Carcinoma Cells Transfected with Small Interfering RNA Targeted against Cyclooxygenase-2
Clin. Cancer Res., October 1, 2005; 11(19): 6980 - 6986.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Syrovets, J. E. Gschwend, B. Buchele, Y. Laumonnier, W. Zugmaier, F. Genze, and T. Simmet
Inhibition of I{kappa}B Kinase Activity by Acetyl-boswellic Acids Promotes Apoptosis in Androgen-independent PC-3 Prostate Cancer Cells in Vitro and in Vivo
J. Biol. Chem., February 18, 2005; 280(7): 6170 - 6180.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. T. Palayoor, M. A. Burgos, A. Shoaibi, P. J. Tofilon, and C. N. Coleman
Effect of Radiation and Ibuprofen on Normoxic Renal Carcinoma Cells Overexpressing Hypoxia-Inducible Factors by Loss of von Hippel-Lindau Tumor Suppressor Gene Function
Clin. Cancer Res., June 15, 2004; 10(12): 4158 - 4164.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. K. Park, Y. M. Chung, B.-G. Kim, Y.-A Yoo, B.-S. Yang, J. S. Kim, and Y. D. Yoo
N'-(phenyl-pyridin-2-yl-methylene)-hydrazine carbodithioic acid methyl ester enhances radiation-induced cell death by targeting Bcl-2 against human lung carcinoma cells
Mol. Cancer Ther., April 1, 2004; 3(4): 403 - 407.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. S. Bisht, C. M. Bradbury, D. Mattson, A. Kaushal, A. Sowers, S. Markovina, K. L. Ortiz, L. K. Sieck, J. S. Isaacs, M. W. Brechbiel, et al.
Geldanamycin and 17-Allylamino-17-demethoxygeldanamycin Potentiate the in Vitro and in Vivo Radiation Response of Cervical Tumor Cells via the Heat Shock Protein 90-Mediated Intracellular Signaling and Cytotoxicity
Cancer Res., December 15, 2003; 63(24): 8984 - 8995.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. T. Palayoor, P. J. Tofilon, and C. N. Coleman
Ibuprofen-mediated Reduction of Hypoxia-inducible Factors HIF-1{alpha} and HIF-2{alpha} in Prostate Cancer Cells
Clin. Cancer Res., August 1, 2003; 9(8): 3150 - 3157.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. N. Coleman
Linking Radiation Oncology and Imaging through Molecular Biology (or Now That Therapy and Diagnosis Have Separated, It's Time to Get Together Again!)
Radiology, July 1, 2003; 228(1): 29 - 35.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Ferrario, K. von Tiehl, S. Wong, M. Luna, and C. J. Gomer
Cyclooxygenase-2 Inhibitor Treatment Enhances Photodynamic Therapy-mediated Tumor Response
Cancer Res., July 15, 2002; 62(14): 3956 - 3961.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. J. Baek, L. C. Wilson, C.-H. Lee, and T. E. Eling
Dual Function of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Inhibition of Cyclooxygenase and Induction of NSAID-Activated Gene
J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1126 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. M. Bradbury, S. Markovina, S. J. Wei, L. M. Rene, I. Zoberi, N. Horikoshi, and D. Gius
Indomethacin-induced Radiosensitization and Inhibition of Ionizing Radiation-induced NF-{kappa}B Activation in HeLa Cells Occur via a Mechanism Involving p38 MAP Kinase
Cancer Res., October 1, 2001; 61(20): 7689 - 7696.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Pyo, H. Choy, G. P. Amorino, J.-s. Kim, Q. Cao, S. K. Hercules, and R. N. DuBois
A Selective Cyclooxygenase-2 Inhibitor, NS-398, Enhances the Effect of Radiation in Vitro and in Vivo Preferentially on the Cells That Express Cyclooxygenase-2
Clin. Cancer Res., October 1, 2001; 7(10): 2998 - 3005.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Shono, P. J. Tofilon, J. M. Bruner, O. Owolabi, and F. F. Lang
Cyclooxygenase-2 Expression in Human Gliomas: Prognostic Significance and Molecular Correlations
Cancer Res., June 1, 2001; 61(11): 4375 - 4381.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. J. Baek, K.-S. Kim, J. B. Nixon, L. C. Wilson, and T. E. Eling
Cyclooxygenase Inhibitors Regulate the Expression of a TGF-{beta} Superfamily Member That Has Proapoptotic and Antitumorigenic Activities
Mol. Pharmacol., April 1, 2001; 59(4): 901 - 908.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
C. Petersen, S. Petersen, L. Milas, F. F. Lang, and P. J. Tofilon
Enhancement of Intrinsic Tumor Cell Radiosensitivity Induced by a Selective Cyclooxygenase-2 Inhibitor
Clin. Cancer Res., June 1, 2000; 6(6): 2513 - 2520.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
, , , , , J. , P. , and
Preferential Enhancement of Tumor Radioresponse by a Cyclooxygenase-2
Cancer Res., March 1, 2000; 60(5): 1326 - 1331.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.